HER2与乳腺癌靶向治疗的研究进展

被引：4

作者：

姜扩 ^{[1
]}

王立锋 ^{[2
]}

裘秀春 ^{[1
]}

机构：

[1] 第四军医大学唐都医院骨肿瘤研究所

[2] 第四军医大学生物化学和分子生物学教研室

来源：

实用癌症杂志 | 2010年 / 25卷 / 04期

关键词：

HER2分子; 乳腺癌; 靶向治疗;

D O I：

暂无

中图分类号：

R737.9 [乳腺肿瘤];

学科分类号：

100214 ;

摘要：

引用

页码：425 / 427+432 +432

页数：4

共 8 条

[1] The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies [J].

Freudenberg, Jaclyn A. ;

Wang, Qiang ;

Katsumata, Makoto ;

Drebin, Jeffrey ;

Nagatomo, Izumi ;

Greene, Mark I. .

EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2009, 87 (01) :1-11

[2] Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo [J].

Liu, Manran ;

Ju, Xiaoming ;

Willmarth, Nicole E. ;

Casimiro, Mathew C. ;

Ojeifo, John ;

Sakamaki, Toshiyuki ;

Katiyar, Sanjay ;

Jiao, Xuanmao ;

Popov, Vladimir M. ;

Yu, Zuoren ;

Wu, Kongming ;

Joyce, David ;

Wang, Chenguang ;

Pestell, Richard G. .

AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (05) :1910-1920

[3]

PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF , in human cancer cell lines[J] . Norazizah Shafee,Stefan Kaluz,Ning Ru,Eric J. Stanbridge.Cancer Letters . 2009 (1)

[4]

EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy[J] . Milanezi,Carvalho,Schmitt.Expert Review of Molecular Diagnostics . 2008 (4)

[5] Unraveling the Biologic and Clinical Complexities of HER2 [J].